PRCT | PROCEPT BioRobotics CorporationNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$20.17
+$0.73 (+3.76%)

PROCEPT BioRobotics Corporation (PRCT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA sits below the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, below both on the weekly and above both on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $20.17 vs 50 $19.33 / 200 $23.22
Projection
No cross projected
Test
No active test
Last cross
Death cross 3 Mar 2025 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $19.20 vs 50 $24.80 / 200 $44.44
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 5 Jan 2026 ยท projected 26 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $20.12 vs 50 $18.67 / 200 $19.93
Projection
No cross projected
Test
No active test
Last cross
Death cross 24 Jun 2026 ยท projected 20 bars out

Cross history

12
crosses on record since 2023
5 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
24 Jun 2026Death4-hour20 bars outNot tested
8 Jun 2026Golden4-hour30 bars out1 bar cross test
week of 5 Jan 2026Death steepweekly26 bars outNot tested
31 Jul 2025Death4-hour10 bars outโ€”
20 Jun 2025Golden4-hour24 bars outโ€”

About PRCT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$21.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.